Akums Drugs and Pharmaceuticals Ltd. has announced the appointment of Amrut Medhekar as Chief Executive Officer of its CDMO business, approved by the company’s Board of Directors in a recent meeting.

In his new role, Medhekar will report directly to Sanjeev Jain and Sandeep Jain, the Managing Directors of Akums Drugs. He joins the company with over 27 years of experience in the pharmaceutical industry, bringing expertise in strategic planning, profit and loss management, team building, digitization, and budgetary control.

Before joining Akums Drugs, Medhekar served as President of India Business at Wockhardt for more than two years. His previous experience also includes a 13-year tenure with the Zydus Group.

Akums’ Managing Directors, Sandeep Jain and Sanjeev Jain, stated, “We are delighted to welcome Amrut Medhekar to our leadership team. With his extensive experience, we are confident Akums will reach new heights under his leadership.”

Medhekar said, “I am honored to join Akums Drugs, a company renowned for its innovation and manufacturing prowess. I look forward to driving growth, enhancing operational efficiencies, and delivering exceptional value to our clients.”

Additionally, he has held roles at Novartis, JK Tyre and Industries, LifeMedicare Biotech, Torrent Pharmaceuticals, and Ranbaxy. Medhekar holds a Master’s in Business Administration in Marketing from Jiwaji University.